These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33956343)

  • 1. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
    Wang V; Geybels MS; Jordahl KM; Gerke T; Hamid A; Penney KL; Markt SC; Freedman M; Pomerantz M; Lee GM; Rana H; Börnigen D; Rebbeck TR; Huttenhower C; Eeles RA; Stanford JL; Consortium P; Berndt SI; Claessens F; Sørensen KD; Park JY; Vega A; Usmani N; Mucci L; Sweeney CJ
    Prostate; 2021 Jul; 81(10):683-693. PubMed ID: 33956343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
    Batra J; Lose F; O'Mara T; Marquart L; Stephens C; Alexander K; Srinivasan S; Eeles RA; Easton DF; Al Olama AA; Kote-Jarai Z; Guy M; Muir K; Lophatananon A; Rahman AA; Neal DE; Hamdy FC; Donovan JL; Chambers S; Gardiner RA; Aitken J; Yaxley J; Kedda MA; Clements JA; Spurdle AB
    PLoS One; 2011; 6(11):e26527. PubMed ID: 22132073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide pleiotropy scan for prostate cancer risk.
    Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
    Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
    Kerns SL; Stock R; Stone N; Buckstein M; Shao Y; Campbell C; Rath L; De Ruysscher D; Lammering G; Hixson R; Cesaretti J; Terk M; Ostrer H; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e21-8. PubMed ID: 23021708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide association study of prostate cancer mortality.
    Penney KL; Pyne S; Schumacher FR; Sinnott JA; Mucci LA; Kraft PL; Ma J; Oh WK; Kurth T; Kantoff PW; Giovannucci EL; Stampfer MJ; Hunter DJ; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2869-76. PubMed ID: 20978177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between metformin medication, genetic variation and prostate cancer risk.
    Lee MJ; Jayalath VH; Xu W; Lu L; Freedland SJ; Fleshner NE; Kulkarni GS; Finelli A; van der Kwast TH; Hamilton RJ
    Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):96-105. PubMed ID: 32424261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survival.
    Xie W; Stopsack KH; Drouin SJ; Fu H; Pomerantz MM; Mucci LA; Lee GM; Kantoff PW
    Prostate; 2019 Jan; 79(1):73-80. PubMed ID: 30141208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.
    Li W; Middha M; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Häggström C; Hallmans G; Rönn AC; Stattin P; Melander O; Ulmert D; Lilja H; Klein RJ
    Eur Urol; 2018 Dec; 74(6):710-719. PubMed ID: 30289108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms influencing prostate-specific antigen concentration may bias genome-wide association studies on prostate cancer.
    Dluzniewski PJ; Xu J; Ruczinski I; Isaacs WB; Platz EA
    Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):88-93. PubMed ID: 25352524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication of a genetic variant for prostate cancer-specific mortality.
    Penney KL; Shui IM; Feng Z; Sesso HD; Stampfer MJ; Stanford JL
    Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):260-3. PubMed ID: 25939514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
    Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
    PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian clock genes and risk of fatal prostate cancer.
    Markt SC; Valdimarsdottir UA; Shui IM; Sigurdardottir LG; Rider JR; Tamimi RM; Batista JL; Haneuse S; Flynn-Evans E; Lockley SW; Czeisler CA; Stampfer MJ; Launer L; Harris T; Smith AV; Gudnason V; Lindstrom S; Kraft P; Mucci LA
    Cancer Causes Control; 2015 Jan; 26(1):25-33. PubMed ID: 25388799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian pathway genetic variation and cancer risk: evidence from genome-wide association studies.
    Mocellin S; Tropea S; Benna C; Rossi CR
    BMC Med; 2018 Feb; 16(1):20. PubMed ID: 29455641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer.
    Kerns SL; Ostrer H; Stock R; Li W; Moore J; Pearlman A; Campbell C; Shao Y; Stone N; Kusnetz L; Rosenstein BS
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1292-300. PubMed ID: 20932654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of prostate cancer risk variants rs10993994 and rs7098889 by CRISPR/Cas9 mediated genome editing.
    Wang X; Hayes JE; Xu X; Gao X; Mehta D; Lilja HG; Klein RJ
    Gene; 2021 Feb; 768():145265. PubMed ID: 33122083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.
    Teerlink CC; Leongamornlert D; Dadaev T; Thomas A; Farnham J; Stephenson RA; Riska S; McDonnell SK; Schaid DJ; Catalona WJ; Zheng SL; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Giles GG; Southey MC; Fitzgerald LM; Rinckleb A; Luedeke M; Maier C; Stanford JL; Ostrander EA; Kaikkonen EM; Sipeky C; Tammela T; Schleutker J; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Xu J; Cancel-Tassin G; Cussenot O; Mandal D; Laurie C; Laurie C; ; ; Thibodeau SN; Eeles RA; Kote-Jarai Z; Cannon-Albright L
    Hum Genet; 2016 Aug; 135(8):923-38. PubMed ID: 27262462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
    Ishak MB; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
    Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RTK/ERK pathway is associated with prostate cancer risk on the SNP level: a pooled analysis of 41 sets of data from case-control studies.
    Chen Y; Li T; Yu X; Xu J; Li J; Luo D; Mo Z; Hu Y
    Gene; 2014 Jan; 534(2):286-97. PubMed ID: 24177231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.
    Shan J; Al-Rumaihi K; Rabah D; Al-Bozom I; Kizhakayil D; Farhat K; Al-Said S; Kfoury H; Dsouza SP; Rowe J; Khalak HG; Jafri S; Aigha II; Chouchane L
    J Transl Med; 2013 May; 11():121. PubMed ID: 23668334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.